Scientific paper - Original scientific paper
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
Haematologica, 102 (2017), 8; 1361-1367. https://doi.org/10.3324/haematol.2017.167080

Gullaksen, Stein-Erik; Skavland, Jørn; Gavasso, Sonia; Tosevski, Vinko; Warzocha, Krzysztof; Dumrese, Claudia; Ferrant, Augustin; Gedde-Dahl, Tobias; Hellmann, Andrzej; Janssen, Jeroen; Labar, Boris; Lang, Alois; Majeed, Waleed; Mihaylov, Georgi; Stentoft, Jesper; Stenke, Leif; Thaler, Josef; Thielen, Noortje; Verhoef, Gregor; Voglova, Jaroslava; Ossenkoppele, Gert; Hochhaus, Andreas; Hjorth-Hansen, Henrik; Mustjoki, Satu; Sopper, Sieghart; Giles, Francis; Porkka, Kimmo; Wolf, Dominik; Gjertsen, Bjørn Tore More authors...

Cite this document

Gullaksen, S. E., Skavland, J., Gavasso, S., Tosevski, V., Warzocha, K., Dumrese, C. ... Gjertsen, B. T. (2017). Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica, 102. (8), 1361-1367. doi: 10.3324/haematol.2017.167080

Gullaksen, Stein Erik, et al. "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib." Haematologica, vol. 102, no. 8, 2017, pp. 1361-1367. https://doi.org/10.3324/haematol.2017.167080

Gullaksen, Stein Erik, Jørn Skavland, Sonia Gavasso, Vinko Tosevski, Krzysztof Warzocha, Claudia Dumrese, Augustin Ferrant, et al. "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib." Haematologica 102, no. 8 (2017): 1361-1367. https://doi.org/10.3324/haematol.2017.167080

Gullaksen, S. E., et al. (2017) 'Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib', Haematologica, 102(8), pp. 1361-1367. doi: 10.3324/haematol.2017.167080

Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, and sur.. Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica [Internet]. 2017 August [cited 2024 November 30];102(8):1361-1367. doi: 10.3324/haematol.2017.167080

S. E. Gullaksen, et al., "Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib", Haematologica, vol. 102, no. 8, pp. 1361-1367, August 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:821605. [Accessed: 30 November 2024]